FDA Authorizes Expanded Use for REGEN-COV mAb

The FDA has authorized an additional use for the COVID-19 monoclonal antibody therapeutic REGEN-COV (casirivimab and imdevimab).

Aug 05, 2021 | Guest Author

  • Webinar, COVID-19

    Webinar: Improving Adolescent Vaccine Coverage – Situation Assessment, Insights, and...

    Join this webinar on Thursday, July 29, 3:00-4:15 pm ET.

    Jul 23, 2021 | Beth Hess

  • COVID-19

    FDA Authorizes Expanded Use for REGEN-COV mAb

    The FDA has authorized an additional use for the COVID-19 monoclonal antibody therapeutic REGEN-COV (casirivimab and imdevimab).

    Aug 05, 2021 | Guest Author

    Webinar, COVID-19

    Webinar: Improving Adolescent Vaccine Coverage – Situation Assessment, Insights, and Tools You Can Use

    Join this webinar on Thursday, July 29, 3:00-4:15 pm ET.

    Jul 23, 2021 | Beth Hess

    3 Newsletters1200 1
    Back to Top